Global losses due to dairy cattle diseases: A comorbidity-adjusted economic analysis

• Published in: Journal of dairy science Vol. 107; no. 9; pp. 6945 - 6970
• Main Authors: Rasmussen, Philip, Barkema, Herman W., Osei, Prince P., Taylor, James, Shaw, Alexandra P., Conrady, Beate, Chaters, Gemma, Muñoz, Violeta, Hall, David C., Apenteng, Ofosuhene O., Rushton, Jonathan, Torgerson, Paul R.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2024; American Dairy Science Association; Elsevier
• Subjects: dairy; disease; economic; impact; disease; dairy; economic; impact
• ISSN: 0022-0302; 1525-3198; 1525-3198
• DOI: 10.3168/jds.2023-24626

The list of standard abbreviations for JDS is available at adsa.org/jds-abbreviations-24. Nonstandard abbreviations are available in the Notes. An economic simulation was carried out over 183 milk-producing countries to estimate the global economic impacts of 12 dairy cattle diseases and health conditions: mastitis (subclinical and clinical), lameness, paratuberculosis (Johne's disease), displaced abomasum, dystocia, metritis, milk fever, ovarian cysts, retained placenta, and ketosis (subclinical and clinical). Estimates of disease impacts on milk yield, fertility, and culling were collected from the literature, standardized, meta-analyzed using a variety of methods ranging from simple averaging to random-effects models, and adjusted for comorbidities to prevent overestimation. These comorbidity-adjusted disease impacts were then combined with a set of country-level estimates for lactational incidence or prevalence or both, herd characteristics, and price estimates within a series of Monte Carlo simulations that estimated and valued the economic losses due to these diseases. It was estimated that total annual global losses are US$65 billion (B). Subclinical ketosis, clinical mastitis, and subclinical mastitis were the costliest diseases modeled, resulting in mean annual global losses of approximately US$18B, US$13B, and US$9B, respectively. Estimated global annual losses due to clinical ketosis, displaced abomasum, dystocia, lameness, metritis, milk fever, ovarian cysts, paratuberculosis, and retained placenta were estimated to be US$0.2B, US$0.6B, US$0.6B, US$6B, US$5B, US$0.6B, US$4B, US$4B, and US$3B, respectively. Without adjustment for comorbidities, when statistical associations between diseases were disregarded, mean aggregate global losses would have been overestimated by 45%. Although annual losses were greatest in India (US$12B), the United States (US$8B), and China (US$5B), depending on the measure of losses used (losses as a percentage of gross domestic product, losses per capita, losses as a percentage of gross milk revenue), the relative economic burden of these dairy cattle diseases across countries varied markedly.